
"Before the mainstream media transfigures Moderna founder and CEO Stephane Bancel into a corporate savior on par with Bill Gates, we'd like to remind investors (and the public) that Moderna and its insiders have demonstrated an eyebrow-raising affinity for pumping the stock with over-hyped press releases then cashing in shares or warrants (all insider stock sales were pre-scheduled divestitures, the insiders' lawyers have argued). Despite receiving $25 million from the Department of Defense's "Defense Advanced Research Projects Agency" - or "Darpa" - Moderna has never disclosed this or any other, government funding in its applications for 126 patents and 154 patent applications."

Be the first to comment